CHRONIC PAIN PATIENTS PUNISHED FOR OPIOID ABUSE BY DOCTORS, PHARMACIES, PAIN CLINICS; GOVERNMENT OVER REACTS
By Blake Farmer Nashville Public Radio A pharmacist in Celina, Tenn., was one of 60 people indicted on charges of opioid-related crimes in April in a multistate sting. John Polston was charged with 21 counts of filling medically unnecessary narcotic prescriptions. He was also Gail Gray’s pharmacist and the person she relied
PELVIC VEIN OBSTRUCTION: VeinCare Centers of Tennessee now implant new BD Venovo stents to open pelvis vein
VeinCare Centers of Tennessee is one of the first clinics in the United States to implant the new BD Venovo stent in obstructed pelvic veins. The Venovo stent is the first stent designed specifically for use in treating obstruction of veins to be approved by the Food and Drug
HHS TO DELIVER VALUE-BASED TRANSFORMATION IN PRIMARY CARE
The U.S. Department of Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma announced the CMS Primary Cares Initiative April 22, a new set of payment models that will transform primary care to deliver better value for patients throughout the
BiosupportMD dietary supplements as adjuncts in venous, lymphatic care*
BiosupportMD is a nutraceutical company created by John Chuback, MD, FACS, RPVI, RVT, RPhS, and his business partners Christopher Tichio and Alexander von Summer in 2015. The company was the brainchild of Dr. Chuback, a board certified general and cardiovascular surgeon who has been specializing in the treatment of
Healogics adds vein ablation to wound care treatments
Healogics, the nation’s largest provider of advanced chronic wound care services, announced in March that they have added vein ablation to their in-house service offerings through a new program called Healogics VeinCare. Healogics CMO William Ennis, DO, MBA, MMM, CPE, said this program allows Healogics to provide patients with a
CAN SOMEONE TELL ME WHAT A PBM REALLY DOES?
By Rachel Bluth It was back-to-school day at the Senate Finance Committee hearing April 9. In the third of a series of hearings on rising drug prices, the senators seemed focused on getting an answer to one central question: What the heck is a pharmacy benefit manager? Pharmacy benefit managers,
AVINGER GETS FDA OK FOR PANTHERIS SV SMALL VESSEL ATHERECTOMY DEVICE
The U.S. Federal Drug Administration granted Aninger’s Pantheris SV small vessel image-guided atherectomy system pre-market approval in eight months. The Pantheris SV is an extension of the Redwood City, California-based company’s lumivascular image-guided atherectomy platform, which it hopes will expand the available market for its Pantheris devices by up
Teleflex gets premarket OK for biomechanical MANTA Closure
Teleflex Inc., a global provider of medical technologies for critical care and surgery, has announced that it received premarket approval from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial
SPRY HEALTH KEEPS TIGHT FOCUS WITH THE LOOP SYSTEM
The Palo Alto, California-based company has received FDA clearance for a wearable that can remotely monitor patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD), allowing the detection of early signs of deterioration before symptoms are noticeable. Spry Health’s tight focus could have significantly beneficial implications for
SVS JOURNAL: EVT IS THE NEW CASH COW FOR NON-VASCULAR DOCTORS; ETHICAL ISSUES RAISED
A new report suggests that providers who are not traditionally associated with the treatment of venous disease are driving the rapid increase in endovenous therapies. A compound annual growth rate of 15 percent has been observed for minimally-invasive procedures to treat superficial venous reflux over the past decade. In the